Sentynl Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.sentynl.com
Copper Histidinate Treatment for Menkes Disease
- Conditions
- Menkes Disease
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Sentynl Therapeutics, Inc.
- Registration Number
- NCT04074512
© Copyright 2025. All Rights Reserved by MedPath